| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Fusion Protein:GART-FOXK1 |
Fusion Protein Summary |
 Fusion gene summary |
| Fusion partner gene information | Fusion gene name: GART-FOXK1 | FusionPDB ID: 32468 | FusionGDB2.0 ID: 32468 | Hgene | Tgene | Gene symbol | GART | FOXK1 | Gene ID | 2618 | 221937 |
| Gene name | phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase | forkhead box K1 | |
| Synonyms | AIRS|GARS|GARTF|PAIS|PGFT|PRGS | FOXK1L | |
| Cytomap | 21q22.11 | 7p22.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | trifunctional purine biosynthetic protein adenosine-3GAR transformylaseGARS-AIRS-GARTglycinamide ribonucleotide formyltransferaseglycinamide ribonucleotide synthetase-aminoimidazole ribonucleotide synthetase-glycinamide ribonucleotide transformylase | forkhead box protein K1MNFmyocyte nuclear factor | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | P22102 | P85037 | |
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000381839, ENST00000381815, ENST00000381831, ENST00000361093, ENST00000497313, ENST00000543717, | ENST00000328914, ENST00000446823, |
| Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 19 X 19 X 7=2527 | 4 X 5 X 3=60 |
| # samples | 21 | 5 | |
| ** MAII score | log2(21/2527*10)=-3.58896443127865 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/60*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context (manual curation of fusion genes in FusionPDB) | PubMed: GART [Title/Abstract] AND FOXK1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | GART(34897075)-FOXK1(4796624), # samples:1 GART(34897076)-FOXK1(4796625), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | GART-FOXK1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. GART-FOXK1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. GART-FOXK1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. GART-FOXK1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. GART-FOXK1 seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF. GART-FOXK1 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. GART-FOXK1 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. GART-FOXK1 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. GART-FOXK1 seems lost the major protein functional domain in Tgene partner, which is a transcription factor due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | FOXK1 | GO:0001678 | cellular glucose homeostasis | 29861159|30700909 |
| Tgene | FOXK1 | GO:0010507 | negative regulation of autophagy | 25402684 |
| Tgene | FOXK1 | GO:0010906 | regulation of glucose metabolic process | 29861159|30700909 |
| Tgene | FOXK1 | GO:0042594 | response to starvation | 25402684 |
| Tgene | FOXK1 | GO:0045892 | negative regulation of transcription, DNA-templated | 17670796|25402684 |
| Tgene | FOXK1 | GO:0045893 | positive regulation of transcription, DNA-templated | 29861159|30700909 |
| Tgene | FOXK1 | GO:0061621 | canonical glycolysis | 30700909 |
| Fusion gene breakpoints across GART (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across FOXK1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
Top |
Fusion Gene Sample Information |
| Fusion gene information from FusionGDB2.0. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | STAD | TCGA-BR-8678-01A | GART | chr21 | 34897076 | - | FOXK1 | chr7 | 4796625 | + |
| ChimerDB4 | STAD | TCGA-BR-8678 | GART | chr21 | 34897075 | - | FOXK1 | chr7 | 4796624 | + |
Top |
Fusion ORF Analysis |
| Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000381815 | GART | chr21 | 34897075 | - | ENST00000446823 | FOXK1 | chr7 | 4796624 | + | 2641 | 1413 | 115 | 1440 | 441 |
| ENST00000381815 | GART | chr21 | 34897075 | - | ENST00000328914 | FOXK1 | chr7 | 4796624 | + | 11544 | 1413 | 115 | 1440 | 441 |
| ENST00000381831 | GART | chr21 | 34897075 | - | ENST00000446823 | FOXK1 | chr7 | 4796624 | + | 2790 | 1562 | 249 | 1589 | 446 |
| ENST00000381831 | GART | chr21 | 34897075 | - | ENST00000328914 | FOXK1 | chr7 | 4796624 | + | 11693 | 1562 | 249 | 1589 | 446 |
| ENST00000381815 | GART | chr21 | 34897076 | - | ENST00000446823 | FOXK1 | chr7 | 4796625 | + | 2641 | 1413 | 115 | 1440 | 441 |
| ENST00000381815 | GART | chr21 | 34897076 | - | ENST00000328914 | FOXK1 | chr7 | 4796625 | + | 11544 | 1413 | 115 | 1440 | 441 |
| ENST00000381831 | GART | chr21 | 34897076 | - | ENST00000446823 | FOXK1 | chr7 | 4796625 | + | 2790 | 1562 | 249 | 1589 | 446 |
| ENST00000381831 | GART | chr21 | 34897076 | - | ENST00000328914 | FOXK1 | chr7 | 4796625 | + | 11693 | 1562 | 249 | 1589 | 446 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000381815 | ENST00000446823 | GART | chr21 | 34897075 | - | FOXK1 | chr7 | 4796624 | + | 0.002301749 | 0.99769825 |
| ENST00000381815 | ENST00000328914 | GART | chr21 | 34897075 | - | FOXK1 | chr7 | 4796624 | + | 0.001108908 | 0.99889106 |
| ENST00000381831 | ENST00000446823 | GART | chr21 | 34897075 | - | FOXK1 | chr7 | 4796624 | + | 0.0029039 | 0.99709606 |
| ENST00000381831 | ENST00000328914 | GART | chr21 | 34897075 | - | FOXK1 | chr7 | 4796624 | + | 0.001151824 | 0.9988482 |
| ENST00000381815 | ENST00000446823 | GART | chr21 | 34897076 | - | FOXK1 | chr7 | 4796625 | + | 0.002301749 | 0.99769825 |
| ENST00000381815 | ENST00000328914 | GART | chr21 | 34897076 | - | FOXK1 | chr7 | 4796625 | + | 0.001108908 | 0.99889106 |
| ENST00000381831 | ENST00000446823 | GART | chr21 | 34897076 | - | FOXK1 | chr7 | 4796625 | + | 0.0029039 | 0.99709606 |
| ENST00000381831 | ENST00000328914 | GART | chr21 | 34897076 | - | FOXK1 | chr7 | 4796625 | + | 0.001151824 | 0.9988482 |
Top |
Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >32468_32468_1_GART-FOXK1_GART_chr21_34897075_ENST00000381815_FOXK1_chr7_4796624_ENST00000328914_length(amino acids)=441AA_BP= MAARVLIIGSGGREHTLAWKLAQSHHVKQVLVAPGNAGTACSEKISNTAISISDHTALAQFCKEKKIEFVVVGPEAPLAAGIVGNLRSAG VQCFGPTAEAAQLESSKRFAKEFMDRHGIPTAQWKAFTKPEEACSFILSADFPALVVKASGLAAGKGVIVAKSKEEACKAVQEIMQEKAF GAAGETIVIEELLDGEEVSCLCFTDGKTVAPMPPAQDHKRLLEGDGGPNTGGMGAYCPAPQVSNDLLLKIKDTVLQRTVDGMQQEGTPYT GILYAGIMLTKNGPKVLEFNCRFGDPECQVILPLLKSDLYEVIQSTLDGLLCTSLPVWLENHTALTVVMASKGYPGDYTKGVEITGFPEA -------------------------------------------------------------- >32468_32468_2_GART-FOXK1_GART_chr21_34897075_ENST00000381815_FOXK1_chr7_4796624_ENST00000446823_length(amino acids)=441AA_BP= MAARVLIIGSGGREHTLAWKLAQSHHVKQVLVAPGNAGTACSEKISNTAISISDHTALAQFCKEKKIEFVVVGPEAPLAAGIVGNLRSAG VQCFGPTAEAAQLESSKRFAKEFMDRHGIPTAQWKAFTKPEEACSFILSADFPALVVKASGLAAGKGVIVAKSKEEACKAVQEIMQEKAF GAAGETIVIEELLDGEEVSCLCFTDGKTVAPMPPAQDHKRLLEGDGGPNTGGMGAYCPAPQVSNDLLLKIKDTVLQRTVDGMQQEGTPYT GILYAGIMLTKNGPKVLEFNCRFGDPECQVILPLLKSDLYEVIQSTLDGLLCTSLPVWLENHTALTVVMASKGYPGDYTKGVEITGFPEA -------------------------------------------------------------- >32468_32468_3_GART-FOXK1_GART_chr21_34897075_ENST00000381831_FOXK1_chr7_4796624_ENST00000328914_length(amino acids)=446AA_BP= MAYRTMAARVLIIGSGGREHTLAWKLAQSHHVKQVLVAPGNAGTACSEKISNTAISISDHTALAQFCKEKKIEFVVVGPEAPLAAGIVGN LRSAGVQCFGPTAEAAQLESSKRFAKEFMDRHGIPTAQWKAFTKPEEACSFILSADFPALVVKASGLAAGKGVIVAKSKEEACKAVQEIM QEKAFGAAGETIVIEELLDGEEVSCLCFTDGKTVAPMPPAQDHKRLLEGDGGPNTGGMGAYCPAPQVSNDLLLKIKDTVLQRTVDGMQQE GTPYTGILYAGIMLTKNGPKVLEFNCRFGDPECQVILPLLKSDLYEVIQSTLDGLLCTSLPVWLENHTALTVVMASKGYPGDYTKGVEIT -------------------------------------------------------------- >32468_32468_4_GART-FOXK1_GART_chr21_34897075_ENST00000381831_FOXK1_chr7_4796624_ENST00000446823_length(amino acids)=446AA_BP= MAYRTMAARVLIIGSGGREHTLAWKLAQSHHVKQVLVAPGNAGTACSEKISNTAISISDHTALAQFCKEKKIEFVVVGPEAPLAAGIVGN LRSAGVQCFGPTAEAAQLESSKRFAKEFMDRHGIPTAQWKAFTKPEEACSFILSADFPALVVKASGLAAGKGVIVAKSKEEACKAVQEIM QEKAFGAAGETIVIEELLDGEEVSCLCFTDGKTVAPMPPAQDHKRLLEGDGGPNTGGMGAYCPAPQVSNDLLLKIKDTVLQRTVDGMQQE GTPYTGILYAGIMLTKNGPKVLEFNCRFGDPECQVILPLLKSDLYEVIQSTLDGLLCTSLPVWLENHTALTVVMASKGYPGDYTKGVEIT -------------------------------------------------------------- >32468_32468_5_GART-FOXK1_GART_chr21_34897076_ENST00000381815_FOXK1_chr7_4796625_ENST00000328914_length(amino acids)=441AA_BP= MAARVLIIGSGGREHTLAWKLAQSHHVKQVLVAPGNAGTACSEKISNTAISISDHTALAQFCKEKKIEFVVVGPEAPLAAGIVGNLRSAG VQCFGPTAEAAQLESSKRFAKEFMDRHGIPTAQWKAFTKPEEACSFILSADFPALVVKASGLAAGKGVIVAKSKEEACKAVQEIMQEKAF GAAGETIVIEELLDGEEVSCLCFTDGKTVAPMPPAQDHKRLLEGDGGPNTGGMGAYCPAPQVSNDLLLKIKDTVLQRTVDGMQQEGTPYT GILYAGIMLTKNGPKVLEFNCRFGDPECQVILPLLKSDLYEVIQSTLDGLLCTSLPVWLENHTALTVVMASKGYPGDYTKGVEITGFPEA -------------------------------------------------------------- >32468_32468_6_GART-FOXK1_GART_chr21_34897076_ENST00000381815_FOXK1_chr7_4796625_ENST00000446823_length(amino acids)=441AA_BP= MAARVLIIGSGGREHTLAWKLAQSHHVKQVLVAPGNAGTACSEKISNTAISISDHTALAQFCKEKKIEFVVVGPEAPLAAGIVGNLRSAG VQCFGPTAEAAQLESSKRFAKEFMDRHGIPTAQWKAFTKPEEACSFILSADFPALVVKASGLAAGKGVIVAKSKEEACKAVQEIMQEKAF GAAGETIVIEELLDGEEVSCLCFTDGKTVAPMPPAQDHKRLLEGDGGPNTGGMGAYCPAPQVSNDLLLKIKDTVLQRTVDGMQQEGTPYT GILYAGIMLTKNGPKVLEFNCRFGDPECQVILPLLKSDLYEVIQSTLDGLLCTSLPVWLENHTALTVVMASKGYPGDYTKGVEITGFPEA -------------------------------------------------------------- >32468_32468_7_GART-FOXK1_GART_chr21_34897076_ENST00000381831_FOXK1_chr7_4796625_ENST00000328914_length(amino acids)=446AA_BP= MAYRTMAARVLIIGSGGREHTLAWKLAQSHHVKQVLVAPGNAGTACSEKISNTAISISDHTALAQFCKEKKIEFVVVGPEAPLAAGIVGN LRSAGVQCFGPTAEAAQLESSKRFAKEFMDRHGIPTAQWKAFTKPEEACSFILSADFPALVVKASGLAAGKGVIVAKSKEEACKAVQEIM QEKAFGAAGETIVIEELLDGEEVSCLCFTDGKTVAPMPPAQDHKRLLEGDGGPNTGGMGAYCPAPQVSNDLLLKIKDTVLQRTVDGMQQE GTPYTGILYAGIMLTKNGPKVLEFNCRFGDPECQVILPLLKSDLYEVIQSTLDGLLCTSLPVWLENHTALTVVMASKGYPGDYTKGVEIT -------------------------------------------------------------- >32468_32468_8_GART-FOXK1_GART_chr21_34897076_ENST00000381831_FOXK1_chr7_4796625_ENST00000446823_length(amino acids)=446AA_BP= MAYRTMAARVLIIGSGGREHTLAWKLAQSHHVKQVLVAPGNAGTACSEKISNTAISISDHTALAQFCKEKKIEFVVVGPEAPLAAGIVGN LRSAGVQCFGPTAEAAQLESSKRFAKEFMDRHGIPTAQWKAFTKPEEACSFILSADFPALVVKASGLAAGKGVIVAKSKEEACKAVQEIM QEKAFGAAGETIVIEELLDGEEVSCLCFTDGKTVAPMPPAQDHKRLLEGDGGPNTGGMGAYCPAPQVSNDLLLKIKDTVLQRTVDGMQQE GTPYTGILYAGIMLTKNGPKVLEFNCRFGDPECQVILPLLKSDLYEVIQSTLDGLLCTSLPVWLENHTALTVVMASKGYPGDYTKGVEIT -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr21:34897075/chr7:4796624) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| GART | FOXK1 |
| FUNCTION: Transcriptional regulator involved in different processes such as glucose metabolism, aerobic glycolysis, muscle cell differentiation and autophagy (By similarity). Recognizes and binds the forkhead DNA sequence motif (5'-GTAAACA-3') and can both act as a transcription activator or repressor, depending on the context (PubMed:17670796). Together with FOXK2, acts as a key regulator of metabolic reprogramming towards aerobic glycolysis, a process in which glucose is converted to lactate in the presence of oxygen (By similarity). Acts by promoting expression of enzymes for glycolysis (such as hexokinase-2 (HK2), phosphofructokinase, pyruvate kinase (PKLR) and lactate dehydrogenase), while suppressing further oxidation of pyruvate in the mitochondria by up-regulating pyruvate dehydrogenase kinases PDK1 and PDK4 (By similarity). Probably plays a role in gluconeogenesis during overnight fasting, when lactate from white adipose tissue and muscle is the main substrate (By similarity). Involved in mTORC1-mediated metabolic reprogramming: in response to mTORC1 signaling, translocates into the nucleus and regulates the expression of genes associated with glycolysis and downstream anabolic pathways, such as HIF1A, thereby regulating glucose metabolism (By similarity). Together with FOXK2, acts as a negative regulator of autophagy in skeletal muscle: in response to starvation, enters the nucleus, binds the promoters of autophagy genes and represses their expression, preventing proteolysis of skeletal muscle proteins (By similarity). Acts as a transcriptional regulator of the myogenic progenitor cell population in skeletal muscle (By similarity). Binds to the upstream enhancer region (CCAC box) of myoglobin (MB) gene, regulating the myogenic progenitor cell population (By similarity). Promotes muscle progenitor cell proliferation by repressing the transcriptional activity of FOXO4, thereby inhibiting myogenic differentiation (By similarity). Involved in remodeling processes of adult muscles that occur in response to physiological stimuli (By similarity). Required to correct temporal orchestration of molecular and cellular events necessary for muscle repair (By similarity). Represses myogenic differentiation by inhibiting MEFC activity (By similarity). Positively regulates Wnt/beta-catenin signaling by translocating DVL into the nucleus (PubMed:25805136). Reduces virus replication, probably by binding the interferon stimulated response element (ISRE) to promote antiviral gene expression (PubMed:25852164). {ECO:0000250|UniProtKB:P42128, ECO:0000269|PubMed:17670796, ECO:0000269|PubMed:25805136, ECO:0000269|PubMed:25852164}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381815 | - | 11 | 22 | 111_318 | 432.6666666666667 | 1011.0 | Domain | Note=ATP-grasp |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381831 | - | 11 | 22 | 111_318 | 432.6666666666667 | 1011.0 | Domain | Note=ATP-grasp |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381839 | - | 11 | 22 | 111_318 | 432.6666666666667 | 1011.0 | Domain | Note=ATP-grasp |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381815 | - | 11 | 22 | 111_318 | 432.6666666666667 | 1011.0 | Domain | Note=ATP-grasp |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381831 | - | 11 | 22 | 111_318 | 432.6666666666667 | 1011.0 | Domain | Note=ATP-grasp |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381839 | - | 11 | 22 | 111_318 | 432.6666666666667 | 1011.0 | Domain | Note=ATP-grasp |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381815 | - | 11 | 22 | 137_199 | 432.6666666666667 | 1011.0 | Nucleotide binding | ATP |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381831 | - | 11 | 22 | 137_199 | 432.6666666666667 | 1011.0 | Nucleotide binding | ATP |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381839 | - | 11 | 22 | 137_199 | 432.6666666666667 | 1011.0 | Nucleotide binding | ATP |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381815 | - | 11 | 22 | 137_199 | 432.6666666666667 | 1011.0 | Nucleotide binding | ATP |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381831 | - | 11 | 22 | 137_199 | 432.6666666666667 | 1011.0 | Nucleotide binding | ATP |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381839 | - | 11 | 22 | 137_199 | 432.6666666666667 | 1011.0 | Nucleotide binding | ATP |
| Tgene | FOXK1 | chr21:34897075 | chr7:4796624 | ENST00000446823 | 6 | 12 | 305_400 | 187.0 | 571.0 | DNA binding | Fork-head | |
| Tgene | FOXK1 | chr21:34897076 | chr7:4796625 | ENST00000446823 | 6 | 12 | 305_400 | 187.0 | 571.0 | DNA binding | Fork-head |
| - Not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000361093 | - | 1 | 11 | 111_318 | 0 | 434.0 | Domain | Note=ATP-grasp |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000361093 | - | 1 | 11 | 111_318 | 0 | 434.0 | Domain | Note=ATP-grasp |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000361093 | - | 1 | 11 | 137_199 | 0 | 434.0 | Nucleotide binding | ATP |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000361093 | - | 1 | 11 | 137_199 | 0 | 434.0 | Nucleotide binding | ATP |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000361093 | - | 1 | 11 | 434_809 | 0 | 434.0 | Region | Note=AIRS |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000361093 | - | 1 | 11 | 810_1010 | 0 | 434.0 | Region | Note=GART |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000361093 | - | 1 | 11 | 818_820 | 0 | 434.0 | Region | Note=5'-phosphoribosylglycinamide binding |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000361093 | - | 1 | 11 | 896_899 | 0 | 434.0 | Region | Note=10-formyltetrahydrofolate binding |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000361093 | - | 1 | 11 | 947_951 | 0 | 434.0 | Region | Note=10-formyltetrahydrofolate binding |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000361093 | - | 1 | 11 | 977_980 | 0 | 434.0 | Region | Note=5'-phosphoribosylglycinamide binding |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381815 | - | 11 | 22 | 434_809 | 432.6666666666667 | 1011.0 | Region | Note=AIRS |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381815 | - | 11 | 22 | 810_1010 | 432.6666666666667 | 1011.0 | Region | Note=GART |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381815 | - | 11 | 22 | 818_820 | 432.6666666666667 | 1011.0 | Region | Note=5'-phosphoribosylglycinamide binding |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381815 | - | 11 | 22 | 896_899 | 432.6666666666667 | 1011.0 | Region | Note=10-formyltetrahydrofolate binding |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381815 | - | 11 | 22 | 947_951 | 432.6666666666667 | 1011.0 | Region | Note=10-formyltetrahydrofolate binding |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381815 | - | 11 | 22 | 977_980 | 432.6666666666667 | 1011.0 | Region | Note=5'-phosphoribosylglycinamide binding |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381831 | - | 11 | 22 | 434_809 | 432.6666666666667 | 1011.0 | Region | Note=AIRS |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381831 | - | 11 | 22 | 810_1010 | 432.6666666666667 | 1011.0 | Region | Note=GART |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381831 | - | 11 | 22 | 818_820 | 432.6666666666667 | 1011.0 | Region | Note=5'-phosphoribosylglycinamide binding |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381831 | - | 11 | 22 | 896_899 | 432.6666666666667 | 1011.0 | Region | Note=10-formyltetrahydrofolate binding |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381831 | - | 11 | 22 | 947_951 | 432.6666666666667 | 1011.0 | Region | Note=10-formyltetrahydrofolate binding |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381831 | - | 11 | 22 | 977_980 | 432.6666666666667 | 1011.0 | Region | Note=5'-phosphoribosylglycinamide binding |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381839 | - | 11 | 22 | 434_809 | 432.6666666666667 | 1011.0 | Region | Note=AIRS |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381839 | - | 11 | 22 | 810_1010 | 432.6666666666667 | 1011.0 | Region | Note=GART |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381839 | - | 11 | 22 | 818_820 | 432.6666666666667 | 1011.0 | Region | Note=5'-phosphoribosylglycinamide binding |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381839 | - | 11 | 22 | 896_899 | 432.6666666666667 | 1011.0 | Region | Note=10-formyltetrahydrofolate binding |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381839 | - | 11 | 22 | 947_951 | 432.6666666666667 | 1011.0 | Region | Note=10-formyltetrahydrofolate binding |
| Hgene | GART | chr21:34897075 | chr7:4796624 | ENST00000381839 | - | 11 | 22 | 977_980 | 432.6666666666667 | 1011.0 | Region | Note=5'-phosphoribosylglycinamide binding |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000361093 | - | 1 | 11 | 434_809 | 0 | 434.0 | Region | Note=AIRS |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000361093 | - | 1 | 11 | 810_1010 | 0 | 434.0 | Region | Note=GART |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000361093 | - | 1 | 11 | 818_820 | 0 | 434.0 | Region | Note=5'-phosphoribosylglycinamide binding |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000361093 | - | 1 | 11 | 896_899 | 0 | 434.0 | Region | Note=10-formyltetrahydrofolate binding |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000361093 | - | 1 | 11 | 947_951 | 0 | 434.0 | Region | Note=10-formyltetrahydrofolate binding |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000361093 | - | 1 | 11 | 977_980 | 0 | 434.0 | Region | Note=5'-phosphoribosylglycinamide binding |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381815 | - | 11 | 22 | 434_809 | 432.6666666666667 | 1011.0 | Region | Note=AIRS |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381815 | - | 11 | 22 | 810_1010 | 432.6666666666667 | 1011.0 | Region | Note=GART |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381815 | - | 11 | 22 | 818_820 | 432.6666666666667 | 1011.0 | Region | Note=5'-phosphoribosylglycinamide binding |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381815 | - | 11 | 22 | 896_899 | 432.6666666666667 | 1011.0 | Region | Note=10-formyltetrahydrofolate binding |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381815 | - | 11 | 22 | 947_951 | 432.6666666666667 | 1011.0 | Region | Note=10-formyltetrahydrofolate binding |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381815 | - | 11 | 22 | 977_980 | 432.6666666666667 | 1011.0 | Region | Note=5'-phosphoribosylglycinamide binding |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381831 | - | 11 | 22 | 434_809 | 432.6666666666667 | 1011.0 | Region | Note=AIRS |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381831 | - | 11 | 22 | 810_1010 | 432.6666666666667 | 1011.0 | Region | Note=GART |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381831 | - | 11 | 22 | 818_820 | 432.6666666666667 | 1011.0 | Region | Note=5'-phosphoribosylglycinamide binding |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381831 | - | 11 | 22 | 896_899 | 432.6666666666667 | 1011.0 | Region | Note=10-formyltetrahydrofolate binding |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381831 | - | 11 | 22 | 947_951 | 432.6666666666667 | 1011.0 | Region | Note=10-formyltetrahydrofolate binding |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381831 | - | 11 | 22 | 977_980 | 432.6666666666667 | 1011.0 | Region | Note=5'-phosphoribosylglycinamide binding |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381839 | - | 11 | 22 | 434_809 | 432.6666666666667 | 1011.0 | Region | Note=AIRS |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381839 | - | 11 | 22 | 810_1010 | 432.6666666666667 | 1011.0 | Region | Note=GART |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381839 | - | 11 | 22 | 818_820 | 432.6666666666667 | 1011.0 | Region | Note=5'-phosphoribosylglycinamide binding |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381839 | - | 11 | 22 | 896_899 | 432.6666666666667 | 1011.0 | Region | Note=10-formyltetrahydrofolate binding |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381839 | - | 11 | 22 | 947_951 | 432.6666666666667 | 1011.0 | Region | Note=10-formyltetrahydrofolate binding |
| Hgene | GART | chr21:34897076 | chr7:4796625 | ENST00000381839 | - | 11 | 22 | 977_980 | 432.6666666666667 | 1011.0 | Region | Note=5'-phosphoribosylglycinamide binding |
| Tgene | FOXK1 | chr21:34897075 | chr7:4796624 | ENST00000328914 | 3 | 9 | 10_96 | 350.0 | 734.0 | Compositional bias | Ala-rich | |
| Tgene | FOXK1 | chr21:34897075 | chr7:4796624 | ENST00000328914 | 3 | 9 | 35_62 | 350.0 | 734.0 | Compositional bias | Pro-rich | |
| Tgene | FOXK1 | chr21:34897075 | chr7:4796624 | ENST00000446823 | 6 | 12 | 10_96 | 187.0 | 571.0 | Compositional bias | Ala-rich | |
| Tgene | FOXK1 | chr21:34897075 | chr7:4796624 | ENST00000446823 | 6 | 12 | 35_62 | 187.0 | 571.0 | Compositional bias | Pro-rich | |
| Tgene | FOXK1 | chr21:34897076 | chr7:4796625 | ENST00000328914 | 3 | 9 | 10_96 | 350.0 | 734.0 | Compositional bias | Ala-rich | |
| Tgene | FOXK1 | chr21:34897076 | chr7:4796625 | ENST00000328914 | 3 | 9 | 35_62 | 350.0 | 734.0 | Compositional bias | Pro-rich | |
| Tgene | FOXK1 | chr21:34897076 | chr7:4796625 | ENST00000446823 | 6 | 12 | 10_96 | 187.0 | 571.0 | Compositional bias | Ala-rich | |
| Tgene | FOXK1 | chr21:34897076 | chr7:4796625 | ENST00000446823 | 6 | 12 | 35_62 | 187.0 | 571.0 | Compositional bias | Pro-rich | |
| Tgene | FOXK1 | chr21:34897075 | chr7:4796624 | ENST00000328914 | 3 | 9 | 305_400 | 350.0 | 734.0 | DNA binding | Fork-head | |
| Tgene | FOXK1 | chr21:34897076 | chr7:4796625 | ENST00000328914 | 3 | 9 | 305_400 | 350.0 | 734.0 | DNA binding | Fork-head | |
| Tgene | FOXK1 | chr21:34897075 | chr7:4796624 | ENST00000328914 | 3 | 9 | 123_175 | 350.0 | 734.0 | Domain | FHA | |
| Tgene | FOXK1 | chr21:34897075 | chr7:4796624 | ENST00000446823 | 6 | 12 | 123_175 | 187.0 | 571.0 | Domain | FHA | |
| Tgene | FOXK1 | chr21:34897076 | chr7:4796625 | ENST00000328914 | 3 | 9 | 123_175 | 350.0 | 734.0 | Domain | FHA | |
| Tgene | FOXK1 | chr21:34897076 | chr7:4796625 | ENST00000446823 | 6 | 12 | 123_175 | 187.0 | 571.0 | Domain | FHA |
Top |
Fusion Protein-Protein Interaction |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
| Gene | PPI interactors |
| Protein-protein interactors based on sequence similarity (STRING) |
| Gene | STRING network |
| GART | |
| FOXK1 |
| - Retained interactions in fusion protein (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost interactions due to fusion (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Tgene | FOXK1 | chr21:34897075 | chr7:4796624 | ENST00000328914 | 3 | 9 | 2_40 | 350.0 | 734.0 | SIN3A and SIN3B | |
| Tgene | FOXK1 | chr21:34897075 | chr7:4796624 | ENST00000446823 | 6 | 12 | 2_40 | 187.0 | 571.0 | SIN3A and SIN3B | |
| Tgene | FOXK1 | chr21:34897076 | chr7:4796625 | ENST00000328914 | 3 | 9 | 2_40 | 350.0 | 734.0 | SIN3A and SIN3B | |
| Tgene | FOXK1 | chr21:34897076 | chr7:4796625 | ENST00000446823 | 6 | 12 | 2_40 | 187.0 | 571.0 | SIN3A and SIN3B |
Top |
Related Drugs to GART-FOXK1 |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to GART-FOXK1 |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies